Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-059047

Chief Financial Officer sold 1,469 shares at $19.77 ($29,048)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Koppikar Utpal Chief Financial Officer 2020-11-17 Sale −1,469 $19.77 $29,048 132,061 D
Open-market sales · 1,469 sh · avg $19.77 · $29,048
Loading xslF345X03/doc4.xml…